Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 34 M41 M38 M511 M24 M 614 M Research & development ————— — Operating income -106 M66 M263 M-313 M210 M 226 M Non-Operating Income, Total -285 M291 M188 M12 M-458 M 33 M Interest expense, net of interest capitalized 1 M1 M02 M— — Non-Operating Income, excl. Interest Expenses -289 M286 M186 M11 M-470 M 13 M Unusual income/expense 3 M4 M2 M-1 M12 M 17 M Pretax income -187 M97 M304 M-380 M81 M 102 M Equity in earnings ————— — Taxes -52 M25 M97 M-17 M18 M 123 M Non-controlling/minority interest 0000— — After tax other income/expense -37 M-8 M-46 M29 M-4 M -29 M Net income before discontinued operations -135 M72 M207 M-363 M63 M -21 M Discontinued operations ————— — Net income -135 M72 M207 M-363 M63 M -21 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -135 M72 M207 M-363 M63 M -21 M Basic earnings per share (Basic EPS) -2.941.584.52-7.951.38 -0.47 Diluted earnings per share (Diluted EPS) -2.941.54.25-7.61.33 -0.52 Average basic shares outstanding 45.85 M45.55 M45.68 M45.69 M45.61 M — Diluted shares outstanding 45.85 M47.91 M48.58 M45.69 M47.43 M — EBITDA 658 M845 M897 M289 M723 M 2.75 B EBIT 54 M775 M836 M215 M631 M 2.46 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 74 M70 M61 M74 M92 M 297 M